249 related articles for article (PubMed ID: 31200996)
1. Paraneoplastic movement disorders: phenomenology, diagnosis, and treatment.
Chirra M; Marsili L; Gallerini S; Keeling EG; Marconi R; Colosimo C
Eur J Intern Med; 2019 Sep; 67():14-23. PubMed ID: 31200996
[TBL] [Abstract][Full Text] [Related]
2. Movement disorders in autoimmune encephalitis and paraneoplastic neurological syndromes.
Honnorat J; Joubert B
Rev Neurol (Paris); 2018 Nov; 174(9):597-607. PubMed ID: 30201423
[TBL] [Abstract][Full Text] [Related]
3. Movement disorders in paraneoplastic and autoimmune disease.
Panzer J; Dalmau J
Curr Opin Neurol; 2011 Aug; 24(4):346-53. PubMed ID: 21577108
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic autoimmune movement disorders.
Lim TT
Parkinsonism Relat Disord; 2017 Nov; 44():106-109. PubMed ID: 29097081
[TBL] [Abstract][Full Text] [Related]
5. Update on paraneoplastic and autoimmune disorders of the central nervous system.
Rosenfeld MR; Dalmau J
Semin Neurol; 2010 Jul; 30(3):320-31. PubMed ID: 20577938
[TBL] [Abstract][Full Text] [Related]
6. [Classic paraneoplastic syndromes: diagnostic and treatment approach].
Gállego Pérez-Larraya J; Dalmau J
Neurologia; 2008 Sep; 23(7):441-8. PubMed ID: 18726722
[TBL] [Abstract][Full Text] [Related]
7. Managing paraneoplastic neurological disorders.
de Beukelaar JW; Sillevis Smitt PA
Oncologist; 2006 Mar; 11(3):292-305. PubMed ID: 16549814
[TBL] [Abstract][Full Text] [Related]
8. Immune-mediated encephalopathies with an emphasis on paraneoplastic encephalopathies.
Pruitt AA
Semin Neurol; 2011 Apr; 31(2):158-68. PubMed ID: 21590621
[TBL] [Abstract][Full Text] [Related]
9. [Paraneoplastic neurological syndromes].
Stich O; Rauer S
Nervenarzt; 2013 Apr; 84(4):455-60. PubMed ID: 23443876
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic epilepsy.
Serafini A; Lukas RV; VanHaerents S; Warnke P; Tao JX; Rose S; Wu S
Epilepsy Behav; 2016 Aug; 61():51-58. PubMed ID: 27304613
[TBL] [Abstract][Full Text] [Related]
11. Paraneoplastic syndromes causing movement disorders.
Dalmau J; Rosenfeld MR
Handb Clin Neurol; 2011; 100():315-21. PubMed ID: 21496591
[TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic movement disorders.
Popławska-Domaszewicz K; Florczak-Wyspiańska J; Kozubski W; Michalak S
Rev Neurosci; 2018 Sep; 29(7):745-755. PubMed ID: 29561731
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune and paraneoplastic movement disorders: An update.
Baizabal-Carvallo JF; Jankovic J
J Neurol Sci; 2018 Feb; 385():175-184. PubMed ID: 29406902
[TBL] [Abstract][Full Text] [Related]
14. [Neurological syndromes, encephalitis].
Yamamoto T; Tsuji S
Gan To Kagaku Ryoho; 2010 Jun; 37(6):995-1005. PubMed ID: 20567100
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic neurological syndromes and onconeural antibodies: clinical and immunological aspects.
Storstein A; Vedeler CA
Adv Clin Chem; 2007; 44():143-85. PubMed ID: 17682342
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy for paraneoplastic neurological disorders.
Dropcho EJ
Expert Opin Biol Ther; 2005 Oct; 5(10):1339-48. PubMed ID: 16197339
[TBL] [Abstract][Full Text] [Related]
17. Paraneoplastic movement disorders.
Mehta SH; Morgan JC; Sethi KD
Curr Neurol Neurosci Rep; 2009 Jul; 9(4):285-91. PubMed ID: 19515280
[TBL] [Abstract][Full Text] [Related]
18. Paraneoplastic neuromuscular disorders.
Sharp L; Vernino S
Muscle Nerve; 2012 Dec; 46(6):841-50. PubMed ID: 23225383
[TBL] [Abstract][Full Text] [Related]
19. Neurological paraneoplastic syndromes: an update.
Berzero G; Psimaras D
Curr Opin Oncol; 2018 Nov; 30(6):359-367. PubMed ID: 30124520
[TBL] [Abstract][Full Text] [Related]
20. Updates in the Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes.
Grativvol RS; Cavalcante WCP; Castro LHM; Nitrini R; Simabukuro MM
Curr Oncol Rep; 2018 Nov; 20(11):92. PubMed ID: 30415318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
